Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 11 of 89, showing 5 Applications out of 444 total, starting on record 51, ending on 55

# Protocol No Study Title Investigator(s) & Site(s)

51.

ECCT/08/08/03   Partners PrEP Study
    Parallel Comparison of Tenofovir and Emtricitabine/Tenofovir Pre-exposure Prophylaxis to Prevent HIV-1 Acquisition  within HIV-1 Discordant Couples.    
Principal Investigator(s)
1. Prof. Connie Celum
Site(s) in Kenya
1. Kenya- Eldoret (Uasin Gishu county)
2. Kenya – Nairobi (Nairobi City county)
3. Kenya – Kisumu (Kisumu county)
4. Kenya – Thika (Uasin Gishu county)
 
View

52.

ECCT/08/20/01   Partners PrEP Study
    Parallel comparison of Tenofovir and Emtricitabine/Tenofovir pre exposure prophylaxis to prevent HIV-1 acquisition within HIV-1 discordant couples   
Principal Investigator(s)
1. James Njogu Kiarie
2. CAREY FARQUHAR,
3. Grace John Stewart
Site(s) in Kenya
1. Nairobi (Nairobi City county)
2. Thika (Kiambu county)
3. Eldoret (Uasin Gishu county)
4. Kisumu (Kisumu county)
 
View

53.

ECCT/21/03/02   PB-SAM
    Pancreatic Enzymes and Bile Acids: A Non-Antibiotic approach to Treat Intestinal Dysbiosis in Acutely Ill Severely Malnourished Children.   
Principal Investigator(s)
1. Robert Bandsma
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Coast General Hospital (Mombasa county)
3. Mbagathi Hospital (Nairobi City county)
4. Migori County Hospital (Migori county)
 
View

54.

ECCT/19/10/03   Smoking Cessation Study for PLHIV
    Optimizing Smoking Cessation Interventions For People Living With Human Immunodeficiency Virus in Nairobi, Kenya   
Principal Investigator(s)
1. Dr. Seth Scott Himelhoch Seth Scott Himelhoch
Site(s) in Kenya
Mathari National Teaching and Referral Hospital
 
View

55.

ECCT/20/05/03   A5381
    Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or with Rifampicin-Containing TB Treatment   
Principal Investigator(s)
1. Victor Mudhune
Site(s) in Kenya
Kisumu Clinical Research Center
 
View